1[1]Delgado G, Bundy BN, Zaino R, et al. A prospective surgical pathological study of stage Ⅰ squamous carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol, 1990,38:352
2[2]Hopkins MP, Morley GW. Radical hysterectomy versus radiation therapy for stage Ⅰ B squamous cell cancer of the cervix. Cancer, 1991,98:272
3[3]Brewster WR, Monk BJ, Ziogas A, et al. Intent - to - treat analysis of stage Ⅰ b and Ⅱ a cervical cancer in the United States: radiotherapy or surgery 1988 ～ 1995. Obstet Gynecol, 2001, 97:248
4[4]Landoni F, Maneo A, Colombo A, et al. Randomised study of radical surgery rersus radiotherapy for stage Ⅰ b ～Ⅱ a cervical cancer. Lancet,1997,350: 535
5[5]Delgado G, Bundy B, Zaino R, et al. Prospective surgical pathological study of disease free interval in patients with stage Ⅰ b squanous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol, 1990, 38:352
6[6]Samlal RAK, van der Velden J, Ketting BW, et al. Disease free interval and recurrence pattern after the Okabayashi variant of Wertheim' s radical hyesterectomy for stage Ⅰ b and Ⅱ a cervical carcinoma. Int J Gynecol Cancer, 1996,6:120
7[7]Schorge JO, Molpus KL, Koelliker D, et al. Stage Ⅰ b and Ⅱ a cervical cancer with negative lymph nodes: the role of adjuvant radiotherapy after radical hysterectomy. Gynecol Oncol, 1997, 66:31
8[8]Sedlis A, Bundy BN, Rotman MZ, et al. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage Ⅰb carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group study. Gynecol Oncol, 1997, 73:177
9[9]BermanML, Keys H, CreasmanW, etal. Survival and pattems of recurrence in cevical cancer metastatic to periaortic lymph nodes (a Gynecology Oncology Group study). Gynecol Oncol, 1984,19:8
10[10]Vigliotti AP, Wen BC, Hussey DH, et al. Expanded pelvic radiotherapy fields for treatment of local - regionally advanced carcinoma of the cervix: outcome and complications. Int J Radiat Oncol Biol Phys, 1992, 23(3) :501
3Wootipoom V,Lekhyananda N,Phungrassami T,et al.Prognostic significance of Bax,bcl-2,and p53 expressions in cervical squamous cell carcinoma treated by radiotherapy[J].Gynecol Oncol,2004,94(3):636-634.
4Holm R,Skomadal H,Helland HA,et al.Immunohistochemical analysis of p53 protein overexpression in normal,premalignant and malignant tissue of the cervix uteri[J].J Pathol,1993,169:21.
5Suzuki Y,Nakano T,Kato S,et al.Immunohistochemical study of cell cycle-associated proteins in adenocarcinoma of the uterine cervix treated with radiotherapy alone:p53 status has a strong impact on prognosis[J].Internat J Radia Oncol,Biol,Phys,2004,60(1):231-236.
6Nicholson RI,Gee JMW,Hsrper ME.EGFR and cancer prognosis[J].EurJ Cancer,2001,37(Suppl 4):S9-S15.
7Sartor CI.Biological modifiers as potential radiosensitizers:targeting the epidermal growth factor receptor family[J].Semin Oncol,2000,27(6 Suppl ll):15-20.
8Kim YT,Park SW,Kim JW.Correlation between expression of EGFR and the prognosis of patients with cervical carcinoma[J].Gynecol Oncol,2002,87(1):84-89.
9Cho NH,Kim YB,Park TK,et al.P63 and EGFR as prognosis predictor in stage 2B radiation treated cervical squamous cell cercinoma[J].Gynecol Oncol,2003,91(2):346-353.
10Achary MP,Jaggernauth W,Gross E,et al.Cell lines from the same cervical carcinoma but with different radiosensitivities exhibit different cDNA microarray patterns of gene expression[J].Cytogenetics & Cell Genetics,2000,91(1-4):39-43.
